Go Deep
Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,832 | -0.3 | 0.19 | 0.10 | 43.57 |
| Oct 2026 | 22,832 | -0.3 | 0.19 | 0.10 | 43.57 |
| Oct 2026 | 21,112 | -0.2 | 0.18 | 0.10 | 40.56 |
| Oct 2026 | 21,037 | -0.2 | 0.17 | 0.10 | 39.59 |
| Oct 2026 | 21,097 | -0.2 | 0.16 | 0.10 | 37.41 |
| Oct 2026 | 21,164 | -0.2 | 0.15 | 0.10 | 35.00 |
Citius Pharmaceuticals, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,493,788.0 | 1,667,298.0 | 3,944,111.0 | 0.0 |
| Net Profit | -8,862,843.0 | -21,231,140.0 | -8,220,785.0 | -7,959,288.0 |
| EPS | -0.3 | -0.9 | -0.4 | — |
Citius Pharmaceuticals, Inc. Revenue & Profit: Last 4 Years
| Line Item | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -37,433,911.0 | -39,138,839.0 | -32,542,912.0 | -33,640,646.0 |
| EPS | -3.4 | -6.0 | -5.6 | -5.8 |
Citius Pharmaceuticals, Inc. Balance Sheet
Balance sheet data isn't available for this company right now.
Owes vs Owns
Citius Pharmaceuticals, Inc. owed $0.47 for every $1 it owned in Jun 2026, up from $0.09 in Sep 2022.
| Period | Jun 2026 | Sep 2025 | Sep 2024 | Sep 2023 | Sep 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.47× | 0.41× | 0.36× | 0.12× | 0.09× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Citius Pharmaceuticals, Inc. Cash Flow
Cash flow data isn't available for this company right now.